Looking for information about TALARIS HEADQUARTERS ADDRESS? Follow the links below to find all the information you are interested in. Addresses, telephones, emails, working hours and other useful information.


Contact Us - Talaris

    https://talaristx.com/contact/
    Mailing Address: Talaris Therapeutics 201 East Jefferson Street, Suite 110B Louisville, KY 40202 . Boston, MA Corporate Office 93 Worcester Street Suite 120 Wellesley, MA 02481 [email protected]. Louisville, KY Cell Processing Facility & Corporate Office 570 S. Preston St. Louisville, KY 40202 Tel: (502) 398-9250 [email protected] ...

Talaris Therapeutics Corporate Headquarters, Office ...

    https://craft.co/talaris-therapeutics/locations
    Talaris Therapeutics headquarters and office locations Talaris Therapeutics is headquartered in Louisville, KY and has 3 office locations across 1 country. View Company

Talaris Therapeutics Company Profile - Office Locations ...

    https://craft.co/talaris-therapeutics
    Jan 08, 2021 · Talaris Therapeutics is a late-clinical stage biotechnology company that is developing cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders.Employees: 69

Home - Talaris Therapeutics

    https://talaristx.com/
    Jun 14, 2021 · June 3, 2021. Talaris Therapeutics Announces Upcoming Presentations on FCR001 at the Virtual 2021 American Transplant Congress. BOSTON and LOUISVILLE, Ky., June 03, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of ...

Talaris Therapeutics - Crunchbase Company Profile & Funding

    https://www.crunchbase.com/organization/talaris-therapeutics
    Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients toFounded: 2002

Investors Talaris Therapeutics, Inc.

    https://ir.talaristx.com/
    May 11, 2021 · After demonstrating robust phase 2 clinical results, Talaris’ lead product candidate, FCR001, and its proprietary therapeutic approach, Facilitated Allo-HSCT Therapy, are currently being assessed in phase 3 clinical trials. Talaris has a cell manufacturing and research location in Louisville, KY and corporate headquarters in Boston, MA.

Company History - Talaris

    https://talaristx.com/about/company-history/
    Talaris Therapeutics Closes $115 Million Series B Financing to support ongoing Phase 3 registration trial of Talaris’ lead product candidate FCR001 in living donor kidney transplant. 2020 Talaris announces FDA clearance of IND for Phase 1/2a trial of FCR001 in rapidly progressive diffuse scleroderma.

Leadership Team - Talaris

    https://talaristx.com/about/team/
    Contact Us; Careers; Leadership Team Team. The Talaris team is composed of highly experienced leaders in the fields of immunology, cell therapy, clinical development, manufacturing, and people development. Scott Requadt. Chief Executive Officer Suzanne Ildstad, MD. …

In addition to information on TALARIS HEADQUARTERS ADDRESS, our site contains many other interesting information about corporate offices. We invite you to view the pages with related information.

Related Corporate Office Information: